Jin Yang Pharmaceutical Co., Ltd. (KOSDAQ:007370)

Market Cap	63.71B
Revenue (ttm)	117.19B
Net Income (ttm)	5.51B
Shares Out	12.91M
EPS (ttm)	465.19
PE Ratio	10.61
Forward PE	n/a
Dividend	150.00 (3.04%)
Ex-Dividend Date	Dec 29, 2025

Volume	38,409
Average Volume	36,264
Open	4,845.00
Previous Close	4,840.00
Day's Range	4,840.00 - 4,945.00
52-Week Range	4,775.00 - 6,890.00
Beta	0.19
RSI	46.75
Earnings Date	n/a

About Jin Yang Pharmaceutical

Jin Yang Pharmaceutical Co., Ltd. engages in the pharmaceutical business in South Korea. The company offers products for anti-diabetics, antivirals, anti-hypertensives, anti-coagulants, antihistamines, antipyretics, and analgesics; digestive, respiratory, and neuropsychiatric system. It also provides drugs for genito-urinary system, anti-osteoporosis drugs, antimicrobials and antibiotics; and over the counter drugs antipyretics and analgesics. It also provides products for digestive, genito-urinary, neuropsychiatric, circulatory, and dermatolog...

• Industry: Pharmaceutical Preparations
• Founded: 1971
• Employees: 220
• Stock Exchange: KOSDAQ
• Ticker Symbol: 007370

Financial Performance

In 2024, Jin Yang Pharmaceutical's revenue was 113.33 billion, an increase of 20.94% compared to the previous year's 93.71 billion. Earnings were 29.69 billion, an increase of 140.63%.